Strength in the pharmaceutical major’s oncology business offset weak China sales, but the company has warned of a potential ...
Obesity drug maker Novo Nordisk forecast slower growth this year after Wegovy sales more than doubled in the final quarter of ...
Japan's Toyota Motor is expected to post its second consecutive quarterly profit drop when it reports third-quarter earnings ...
By Helen Reid and Isabelle Yr Carlsson COPENHAGEN (Reuters) -Danish jewellery maker Pandora said on Wednesday that its growth ...
International Business Machines Corp. gave a stronger-than-expected revenue growth outlook for the coming years led by the ...
The Danish pharmaceutical company expects sales growth to slow this year as capacity constraints, intensifying competition ...
The pharma major beat analysts’ expectations in the fourth quarter of 2024, despite looming competition for its top heart ...
There’s another important datapoint to be optimistic about: sales at American small businesses grew an average of 0.8 percent ...
Fast-food restaurant owner Yum Brands is expecting stronger sales growth this year after it moves past challenges in its Middle East markets.
Seeking Alpha on MSN20h
Veralto targets low to mid-single-digit core sales growth in 2025 with $3.60–$3.70 EPS guidanceVeralto Corporation delivered all-time high annual sales of $5.2 billion in 2024, with 3.7% core sales growth and an adjusted earnings per share increase of 11% to $3.54. Free cash flow generation ...
Gilead Sciences, Inc.'s strong sales growth in Veklury, Livdelzi, and Trodelvy shows promise for long-term financial success.
We recently compiled a list of the 7 High Growth Travel Services Stocks For 2025. In this article, we are going to take a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results